Home The Word Brain	My Amedeo FAQ Privacy About
	CC Journal Club Our weekly journal club for junior residents and medical students

Leukemia

Free Subscription Articles published in Exp Hematol Retrieve available abstracts of 26 articles: HTML format

Single Articles

March 2025
1. GUL AZ, Selek S, Bekiroglu S, Demirel M, et al
   Serum NMR metabolomics in distinct subtypes of hematologic malignancies.
   Exp Hematol. 2025;143:104710.
   PubMed     Abstract available
   
   
   
2. SARCHI M, Doulatov S
   Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs.
   Exp Hematol. 2025;143:104697.
   PubMed     Abstract available
   
   
   
3. GUIRGUIS AA
   RNA methylation: where to from here for hematologic malignancies?
   Exp Hematol. 2025;143:104694.
   PubMed     Abstract available
   
   
   February 2025
4. TACHIBANA T, Izumi A, Arai S, Takeda T, et al
   Preconditioning intervention before allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
   Exp Hematol. 2025 Feb 12:104746. doi: 10.1016/j.exphem.2025.104746.
   PubMed     Abstract available
   
   
   
5. DE GROOT AP, Nguyen H, Pouw JS, Weersing E, et al
   CBX7 inhibitors affect H3K9 methyltransferase-regulated gene repression in leukemic cells.
   Exp Hematol. 2025;142:104691.
   PubMed     Abstract available
   
   
   January 2025
6. AMOR AR, Enlund S, Sinha I, Jiang Q, et al
   A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells.
   Exp Hematol. 2025 Jan 8:104712. doi: 10.1016/j.exphem.2025.104712.
   PubMed     Abstract available
   
   
   November 2024
7. QU Y, Shourabizadeh H, Subramanian A, Aleman DM, et al
   DIFFERENTIAL IMPACT OF CD34+ CELL DOSE FOR DIFFERENT AGE GROUPS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A MACHINE LEARNING-BASED DISCOVERY.
   Exp Hematol. 2024 Nov 22:104684. doi: 10.1016/j.exphem.2024.104684.
   PubMed     Abstract available
   
   
   October 2024
8. KOHNKE T, Feng Y, Majeti R
   A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research.
   Exp Hematol. 2024 Oct 1:104652. doi: 10.1016/j.exphem.2024.104652.
   PubMed     Abstract available
   
   
   September 2024
9. KHAMARI R, Degand C, Fovez Q, Trinh A, et al
   Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.
   Exp Hematol. 2024;137:104253.
   PubMed     Abstract available
   
   
   August 2024
10. CAMIOLO G, Mullen CG, Ottersbach K
    Mechanistic insights into the developmental origin of pediatric hematologic disorders.
    Exp Hematol. 2024;136:104583.
    PubMed     Abstract available
    
    
    June 2024
11. ONG KOK, Mok MMH, Niibori-Nambu A, Du L, et al
    Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.
    Exp Hematol. 2024 Jun 12:104255. doi: 10.1016/j.exphem.2024.104255.
    PubMed     Abstract available
    
    
    
12. STRAUBE J, Janardhanan Y, Haldar R, Bywater MJ, et al
    Immune control in acute myeloid leukemia.
    Exp Hematol. 2024 Jun 12:104256. doi: 10.1016/j.exphem.2024.104256.
    PubMed     Abstract available
    
    
    
13. ROGERS JH, Rosen A, Reyes JM, Ketkar S, et al
    Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.
    Exp Hematol. 2024 Jun 2:104248. doi: 10.1016/j.exphem.2024.104248.
    PubMed     Abstract available
    
    
    
14. XU JJ, Viny AD
    Chromatin organization in myelodysplastic syndrome.
    Exp Hematol. 2024;134:104216.
    PubMed     Abstract available
    
    
    May 2024
15. ZHOU Q, Li Z, Xi Y
    EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
    Exp Hematol. 2024;133:104175.
    PubMed     Abstract available
    
    
    March 2024
16. PANTING RG, Kotecha RS, Cheung LC
    The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia.
    Exp Hematol. 2024 Mar 27:104212. doi: 10.1016/j.exphem.2024.104212.
    PubMed     Abstract available
    
    
    
17. GOSWAMI M, Bose PD
    Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.
    Exp Hematol. 2024 Mar 23:104211. doi: 10.1016/j.exphem.2024.104211.
    PubMed     Abstract available
    
    
    
18. LIU Q, Zhai Y, Hui Y, Chen J, et al
    Identification of Red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
    Exp Hematol. 2024 Mar 18:104206. doi: 10.1016/j.exphem.2024.104206.
    PubMed     Abstract available
    
    
    February 2024
19. TANAKA T, Kudo K, Kanezaki R, Yuzawa K, et al
    Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome.
    Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
    PubMed     Abstract available
    
    
    
20. RANDALL J, Evans K, Watts B, Kosasih HJ, et al
    IN VIVO ACTIVITY OF THE SECOND-GENERATION PROTEASOME INHIBITOR IXAZOMIB AGAINST PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA XENOGRAFTS.
    Exp Hematol. 2024 Feb 4:104176. doi: 10.1016/j.exphem.2024.104176.
    PubMed     Abstract available
    
    
    
21. MERZ AMA, Platzbecker U
    Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
    Exp Hematol. 2024;130:104130.
    PubMed     Abstract available
    
    
    December 2023
22. ALQAZZAZ MA, Luciani GM, Vu V, Machado RM, et al
    Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations.
    Exp Hematol. 2023 Dec 8:S0301-472X(23)01773-3. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available
    
    
    
23. BUROCZIOVA M, Grusanovic S, Vanickova K, Kosanovic S, et al
    Chronic inflammation promotes cancer progression as a second hit.
    Exp Hematol. 2023;128:30-37.
    PubMed     Abstract available
    
    
    October 2023
24. XIE Y, Tan L, Wu K, Li D, et al
    MiR-455-3p mediates PPARalpha through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells.
    Exp Hematol. 2023 Oct 5:S0301-472X(23)01734-4. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available
    
    
    September 2023
25. GUARNERA L, Santinelli E, Galossi E, Cristiano A, et al
    Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.
    Exp Hematol. 2023 Sep 21:S0301-472X(23)01705.
    PubMed     Abstract available
    
    
    
26. HAN L, Wu J, Lyu X, Yu J, et al
    Genetic Mutation Signature for Relapse Prediction in Normal Karyotype Acute Myeloid Leukemia.
    Exp Hematol. 2023 Sep 20:S0301-472X(23)01706.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.